DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-69.56%
US · US
GM.US latest organized financial period shows revenue declined -1.29% YoY and net income declined -55.11% YoY. Current price is about 76.23 USD, while the model base case is about 93.12 USD; the current price sits -18.1% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Annual financial metrics with switchable views. · Unit: USD
Price date: 2026/04/29 · Updated: 2026/04/29 15:28
Hover each model row to inspect formulas and inputs.
-18.14%
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-69.56%
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
-21.88%
Solves the forward FCF growth rate implied by the current price.
Current price implies roughly -10.0% annualized FCF growth.
Estimates earnings power value without assuming growth.
-14.02%
Updated: 2026/04/29 15:28
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2025/12/31 | Asset impairment | Impairment | -2B USD | Medium |
| 2025/12/31 | Restructuring charges | Restructuring | -4B USD | Medium |
| 2024/12/31 | Asset impairment | Impairment | -1B USD | Medium |
| 2024/12/31 | Restructuring charges | Restructuring | -3B USD | Medium |
| 2023/12/31 | Asset impairment | Impairment | -495M USD | Medium |
| 2023/12/31 | Restructuring charges | Restructuring | -4B USD | Medium |
| 2022/12/31 | Asset impairment | Impairment | -28M USD | Medium |
| 2022/12/31 | Restructuring charges | Restructuring | -1B USD | Medium |
| 2021/12/31 | Asset impairment | Impairment | -9M USD | Medium |
| 2021/12/31 | Restructuring charges | Restructuring | -512M USD | Medium |
| 2020/12/31 | Asset impairment | Impairment | -329M USD | Medium |
| 2020/12/31 | Restructuring charges | Restructuring | -1B USD | Medium |
| 2026/03/31 | Asset impairment | Impairment | -20M USD | Medium |
| 2026/03/31 | Restructuring charges | Restructuring | -845M USD | Medium |
| 2025/09/30 | Asset impairment | Impairment | -2B USD | Medium |
| 2025/09/30 | Restructuring charges | Restructuring | -975M USD | Medium |
| 2025/06/30 | Asset impairment | Impairment | -28M USD | Medium |
| 2025/06/30 | Restructuring charges | Restructuring | -689M USD | Medium |
| 2025/03/31 | Restructuring charges | Restructuring | -207M USD | Medium |
| 2024/09/30 | Asset impairment | Impairment | -956M USD | Medium |
| 2024/09/30 | Restructuring charges | Restructuring | -2B USD | Medium |
| 2024/06/30 | Asset impairment | Impairment | -2B USD | Medium |
| 2024/06/30 | Restructuring charges | Restructuring | -1B USD | Medium |
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | 185B USD | 3B USD | 9B USD | 18B USD | 3.27 | 10.5 |
| 2024/12/31 | Annual | 187B USD | 6B USD | 10B USD | 9B USD | 6.37 | 10.93 |
| 2023/12/31 | Annual | 172B USD | 10B USD | 15B USD | 10B USD | 7.32 | 10.81 |
| 2022/12/31 | Annual | 157B USD | 10B USD | 11B USD | 7B USD | 6.13 | 6.91 |
| 2021/12/31 | Annual | 127B USD | 10B USD | 11B USD | 8B USD | 6.7 | 7.05 |
Total revenue recognized in each fiscal year.
Adjusted close trend. Current price sample covers: 2025/04/16 - 2026/04/29.